Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 18, 2026
A 48-week, Randomized Controlled Trial of Doravirine for Individuals with HIV and Obesity on Integrase Inhibitors and Tenofovir Alafenamide: The Do IT Study (ACTG A5391)John R Koethe, Jordan E Lake, Amy Kantor, et al.Journal of Clinical Pharmacology|June 25, 2021
Pharmacokinetics of Ruxolitinib in HIV Suppressed Individuals on Antiretroviral Agent Therapy from the ACTG A5336 StudySelwyn J Hurwitz, Sijia Tao, Christina Gavegnano, et al.The Journal of Infectious Diseases|July 10, 2020
An Evaluation of Baseline Kidney Function in the REPRIEVE Trial of Pitavastatin in Human Immunodeficiency VirusEdgar T Overton, Amy Kantor, Kathleen V Fitch, et al.AIDS (London, England)|September 16, 2024
Proteinuria and albuminuria among a global primary cardiovascular disease prevention cohort of people with HIVEdgar T Overton, Amy Kantor, Kathleen V Fitch, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 11, 2021
Randomized Trial of Ruxolitinib in Antiretroviral-Treated Adults With Human Immunodeficiency VirusVincent C Marconi, Carlee Moser, Christina Gavegnano, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 6, 2023
One Week of Oral Camostat Versus Placebo in Nonhospitalized Adults With Mild-to-Moderate Coronavirus Disease 2019: A Randomized Controlled Phase 2 TrialNikolaus Jilg, Kara W Chew, Mark J Giganti, et al.The Journal of Infectious Diseases|July 10, 2020
Correlates and Timing of Reproductive Aging Transitions in a Global Cohort of Midlife Women With Human Immunodeficiency Virus: Insights From the REPRIEVE TrialMarkella V Zanni, Judith S Currier, Amy Kantor, et al.The Lancet. HIV|January 20, 2025
Performance of the pooled cohort equations and D:A:D risk scores among individuals with HIV in a global cardiovascular disease prevention trial: a cohort study leveraging data from REPRIEVESteven K Grinspoon, Markella V Zanni, Virginia A Triant, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 2, 2022
Factors Associated With Systemic Immune Activation Indices in a Global Primary Cardiovascular Disease Prevention Cohort of People With Human Immunodeficiency Virus on Antiretroviral TherapySara E Looby, Amy Kantor, Tricia H Burdo, et al.Pageof 2